NCT00755690

Brief Summary

This study is designed to describe the physiological response to increased and decreased dietary phosphate intake on various parameters of mineral metabolism in the blood and urine of individuals with Chronic Kidney Disease stage 3 and 4 with normal serum phosphate levels. This detailed study will give us a far greater understanding of the role of diet in abnormal mineral homeostasis early in the progression of this chronic disease. The findings of this study will help both physicians and dietitians better determine the optimal time to introduce dietary therapy in CKD.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2008

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

September 17, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 19, 2008

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

February 19, 2014

Status Verified

February 1, 2014

Enrollment Period

1.5 years

First QC Date

September 17, 2008

Last Update Submit

February 17, 2014

Conditions

Keywords

Chronic Kidney DiseaseCKDDietDietary PhosphateMineral MetabolismFGF-23

Outcome Measures

Primary Outcomes (1)

  • FGF-23

    5 days

Secondary Outcomes (1)

  • Serum calcium, phosphate, PTH, 25 and 1,25 vitamin D and fractional phosphate excretion.

    5 days

Study Arms (3)

1

ACTIVE COMPARATOR

High/ Low Phosphate diet I. A five-day low phosphate diet / A five-day low phosphate diet with the addition of a phosphate binder / A five-day high phosphate diet. II. A five-day low phosphate diet / A five-day high phosphate diet / A five-day low phosphate diet with the addition of a phosphate binder III. A five-day high phosphate diet / A five-day low phosphate diet with the addition of a phosphate binder / A five-day low phosphate diet. IV. A five-day high phosphate diet / A five-day low phosphate diet / A five-day low phosphate diet with the addition of a phosphate binder. V. A five-day low phosphate diet with the addition of a phosphate binder / A five-day low phosphate diet / A five-day high phosphate diet. VI. A five-day low phosphate diet with the addition of a phosphate binder / A five-day high phosphate diet / A five-day low phosphate diet.

Behavioral: High/ Low Phosphate diet

2

ACTIVE COMPARATOR

High/ Low Phosphate diet

Behavioral: High/ Low Phosphate diet

3

ACTIVE COMPARATOR

High/ Low Phosphate diet

Behavioral: High/ Low Phosphate diet

Interventions

Low phosphate diet (750mg/day).

1

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • CKD patients with CKD stage 3 and 4 (eGFR \< 60 ml/min and \> 15 ml/min per 1.73 m2, not requiring dialysis).
  • Normal serum phosphate stable over three months (\> 0.87 mmol/L and \< 1.70 mmol/L)
  • Not yet following a low phosphate diet as reported by the patient or the renal dietitian (\<1500mg/d)
  • Over 19 years of age

You may not qualify if:

  • Body mass index \<20 kg/m2
  • Current use of phosphate binders or active vitamin D or phenytonin (which induces vitamin D catabolism)
  • Primary parathyroid defects
  • Diagnosed osteoporosis
  • Gut absorption defects
  • Liver disease
  • Pregnancy or lactation
  • Patients hospitalised within the last 4 weeks

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Paul's Hospital

Vancouver, British Columbia, Canada

Location

MeSH Terms

Conditions

Kidney DiseasesRenal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesRenal InsufficiencyChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Adeera Levin, MD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 17, 2008

First Posted

September 19, 2008

Study Start

September 1, 2008

Primary Completion

March 1, 2010

Study Completion

March 1, 2010

Last Updated

February 19, 2014

Record last verified: 2014-02

Locations